.
There are no recommended diagnostic criteria for transient congenital hypothyroidism (CH)
during early childhood. In this study, we aimed to identify the factors that distinguish
permanent (P)- and transient (T)-CH. We retrospectively analyzed the clinical,
biochemical, and imaging data of 42 children with a definitive diagnosis of P- or T-CH by
re-evaluation tests at our institution from November 1986 to October 2019. Patients who
continued levothyroxine (L-T
4
) treatment after the re-evaluation tests were
classified as group P (n = 19), while patients who were diagnosed with T-CH and
discontinued L-T
4
treatment were classified as group T (n = 23). Initial
testing performed during infancy showed that the mean serum TSH and free T4 (FT4) levels
did not differ significantly between groups P and T. None of the patients in group T
required an increased dosage of L-T
4
at the age of 3 yr and above while 85% of
the patients in group P required increased dosages of L-T
4
. Hence, T-CH was
suspected in patients who did not require an increase in L-T
4
dosage at the age
of 3 yr and above.
Wolfram syndrome (WS) is a monogenic diabetes caused by variants of the WFS1 gene. It is characterized by diabetes mellitus (DM) and optic atrophy. Individuals with WS initially present with autoantibody-negative type 1 DM (type 1B DM; T1BDM). The diagnosis is often delayed or misdiagnosed, even after visual impairment becomes apparent. We report a case of WS diagnosed by ophthalmologic screening before the appearance of visual impairment. A 7-year-old male patient developed T1BDM at the age of 3 years. At 6 years of age, his endogenous insulin secretion decreased but was not completely absent, and glycemic control was good with insulin treatment. Fundus examination at that time revealed optic nerve head pallor, and
WFS1
gene analysis confirmed a compound heterozygous variant (c.2483delinsGGA/c.1247T>A). Ophthalmological screening can help in early diagnosis of WS in T1BDM, especially when endogenous insulin secretion is preserved, which would facilitate effective treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.